Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $500.65 | Total: $2,503.25 |
| 1 | 10 | $424.08 | Total: $4,240.80 |
| 1 | 25 | $359.29 | Total: $8,982.25 |
| 1 | 50 | $306.28 | Total: $15,314.00 |
| 1 | 100 | $265.05 | Total: $26,505.01 |
Overview
Levosemotiadil?SA 3212? is a novel calcium antagonist and a very potent inhibitor of low-density lipoprotein oxidation.Levosemotiadil may be used to prevent lethal cardiac arrhythmias.
Chemical Properties
| Molecular Formula | C29H32N2O6S |
| Molecular Weight | 536.64 |
| CAS Numbers | 116476-16-5 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O(CCCN(CCOC=1C=C2C(=CC1)OCO2)C)C3=C(C=C(OC)C=C3)[C@@H]4SC=5C(N(C)C4=O)=CC=CC5 |
Storage and Handling
0C Short Term, -20C Long Term
References
Ueda K,et al. Enantioselective local disposition of semotiadil [R-enantiomer] and levosemotiadil [S-enantiomer] in perfused rat liver. Drug Metab Dispos. 1997 Mar;25[3] 281-6.